Adare Pharma Solutions, a global technology-driven CDMO focused on oral dosage forms, has completed an expansion of its Pessano facility in Milan, Italy, significantly increasing the company’s European packaging & warehousing capacity.

Construction of the new dedicated packaging and warehouse expansion is complete and has been authorized by AIFA, the Italian medicines agency. The facility is currently producing validation and commercial batches.

The purpose-built 2,800 square-meter packaging hall houses a Marchesini Integra 220S MA260 blister line, featuring integrated Robocombi ‘pick and place’ and SeaVision serialization capabilities. The line is designed for high-efficiency packaging of tablets and capsules into a wide range of formats including Aclar, Triplex, PVC, PVDC, and Alu-Alu blisters, with an annual capacity of more than 50 million blisters.

Additionally, the new building accommodates an expanded warehouse with capacity for over 900 pallets, infrastructure to support up to four future packaging lines, and dedicated areas for manual packaging, quality control, in-process testing, and serialized materials storage.

“The investment in our Milan facility reflects our ongoing commitment to expanding capacity and capabilities for our customers in Europe,” said Tom Sellig, CEO of Adare Pharma Solutions. “With high-speed blistering, modern serialization systems, and a team of experienced packaging experts, our Pessano site is fully equipped to bring customers’ products to market quickly and efficiently.”

With a footprint of 20,400 square meters, the Pessano facility provides R&D services to expedite formulation and process development, and seamless integrated transition to manufacturing. A wide range of solid dosage forms at both clinical and commercial scales can be produced, including granules, capsules, and tablets. The facility also offers controlled substance and organic solvent capabilities.